Navigation Links
Stent Studies Tied to Rapid Changes in Use
Date:7/28/2009

Fast dissemination of data may become main stimulus for change, experts say

TUESDAY, July 28 (HealthDay News) -- Rapid dissemination of new data about the risks posed by drug-eluting stents led to an almost immediate decrease in the use of the stents, according to a new report.

Drug-eluting stents are coated with drugs meant to prevent re-narrowing of coronary arteries.

An analysis of patient registries showed that between January and September 2006, about 90 percent of people who had a type of heart attack called a non-ST-elevation myocardial infarction and underwent coronary stent implantation received drug-eluting stents.

That September, a number of studies presented at a European Society of Cardiology meeting said that the risk of blood clots was higher among people who received drug-eluting stents than among those who received bare-metal stents.

By the end of March 2007, the use of drug-eluting stents had declined to 67 percent and continued to drop to 58 percent by the start of 2008, the researchers found. Their study is published online in Circulation: Cardiovascular Quality and Outcomes.

"There was a rapid change of practice patterns after these presentations in September 2006," the study's lead author, Dr. Matthew T. Roe, an associate professor of medicine at Duke University Medical Center and the Duke Clinical Research Institute in Durham, N.C., said in an American Heart Association news release. "To our knowledge, this was the most rapid change in practice patterns in cardiology. We presume it was because of rapid uptake of information."

The findings suggest that fast distribution of new information through media and scientific outlets could become the "predominant stimulus for change in practice in the future," Roe and his colleagues said.

Dr. Clyde W. Yancy, president of the American Heart Association, said in the news release that the study "demonstrates the dynamic shifts that are occurring in the distribution of medical information."

"The opportunity to widely share important findings that promptly impact practice is becoming a powerful tool to drive change," Yancy said. "The requirements for prompt but thorough peer review and nimble responsiveness to new data are evident. Managing this new health IT space will require focus, assessment and realignment."

More information

The Society for Vascular Surgery has more about angioplasty and stenting.



-- Robert Preidt



SOURCE: American Heart Association, news release, July 28, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. QHR Client Hospitals Lauded for Consistently High Quality Standards, Exceeding Patient Expectations
2. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
3. AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner(TM) Prostatic Stent
4. CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System
5. Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
6. Newest Coated Stent Does Well in Real-World Trial
7. AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism, Freedom of Choice, Freedom of Practice and Universal Access for Patients
8. Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
9. InstaMed Achieves CAQH CORE Rules Certification, Streamlines Provider Access to Consistent Electronic Eligibility, Benefits and Patient Financial Liability Data
10. Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
11. Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stent Studies Tied to Rapid Changes in Use
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology: